Untapped Emerging Countries Will Evolve Into Major Radioactive Stents Market

Radioactive Stents Market


Radioactive stents refer to small expandable tubes that are used in prevention of restenosis and coronary artery lesions, and in improving catheter-based revascularization. These stents are widely utilized in cancer treatment as they utilize high-energy gamma rays that destroy the cancer cells and prevent their proliferation.

Drivers & Restraints

The global market is anticipated to rise at a considerable rate during the forecast period. Emergence of innovative radioactive stents, Increase in incidence of coronary artery disease, and improved clinical outcomes due to stenting drive the market growth. In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes and obesity, and improved insurance & reimbursement towards radioactive stents supplement the market growth.

Sample Link Here: https://www.crystalmarketresearch.com/report-sample/HC0912760



Product Type-

Retrograde Stents

Antegrade Stents

Internal (double-j) Stents

Iodine-125 Radioactive Stents







Percutaneous Nephrolithotomy


Neointimal Hyperplasia

Esophageal Cancer

Biliary Cancer



Regional Analysis

The market has been segment into North America, South America, Europe, Asia-Pacific, and Middle East and Africa. R&D in the field of radiotherapy stents and lucrative opportunities in emerging economies of Asia Pacific is anticipated to create new opportunities during the forecast period.

Purchase Link Here: https://www.crystalmarketresearch.com/checkout/HC0912760



C.R. Bard, Inc.

Cook Medical Inc.

Medline Industries Ltd

Pnn Medical A/S

Allium Medical Solutions Ltd.

APC Cardiovascular Ltd.

Micro-Tech Pvt. Ltd.

Changzhou Zhiye Co Ltd.

Aetna Inc.

Abbott Laboratories